ISpecimen Q2 2024 GAAP EPS $(0.19) Beats $(0.28) Estimate, Sales $2.864M Miss $2.881M Estimate
ISpecimen Q2 2024 GAAP EPS $(0.19) Beats $(0.28) Estimate, Sales $2.864M Miss $2.881M Estimate
iSpecimen 2024年第二季度GAAP每股收益爲$(0.19)，超出$(0.28)的預期，銷售額爲286.4萬美元，低於預期的288.1萬美元。
iSpecimen (NASDAQ:ISPC) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0.28) by 32.14 percent. This is a 51.28 percent increase over losses of $(0.39) per share from the same period last year. The company reported quarterly sales of $2.864 million which missed the analyst consensus estimate of $2.881 million by 0.59 percent. This is a 76.25 percent increase over sales of $1.625 million the same period last year.
iSpecimen（納斯達克：ISPC）報告每股虧損0.19美元，超過分析師共識預期的0.28美元的32.14％。這比去年同期每股虧損0.39美元增加了51.28％。該公司報告季度銷售額爲286.4萬美元，低於分析師共識預期的288.1萬美元0.59％。這是相同期間162.5萬美元銷售額的76.25％增長。
資訊熱榜
更新時間